About SDIX
Creating Advantage
SDIX, (Nasdaq: SDIX ) is a biotechnology company, expert at creating advantage by providing a broad range of quality, innovative and effective immuno-solutions to the Pharmaceutical, Biotechnology, Diagnostics, and Food Safety markets. For 20 years, SDIX has developed antibodies which advance its customers’ immuno-based work - reducing time, labor, and costs while increasing accuracy and reliability of results.
SDIX offers a full suite of integrated immuno-solution capabilities including assay design, development and production. In life science markets, SDIX capabilities are being used to help discover the mechanisms of disease, facilitate the development of new drugs, and provide mechanisms for rapid diagnosis.
SDIX is lead by a management team of:
Fran DiNuzzo, President and CEO
Kevin
Bratton, VP of Finance and CFO
Dr.
Klaus Lindpaintner, VP R&D and CSO
The SDIX Board of Directors
Strategic Diagnostics Inc. d/b/a SDIX. Listed on the NASDAQ: SDIX
SDIX is proud to have earned a number of certificates which shows our dedication to having a quality
and respected operations.
SDIX's News & Media will help you answer your questions about our latest Press Releases, Product News, Upcoming Events and Publications.Publications from SDIX authors and about our products and services.
Find out if SDIX will be exhibiting at the shows you'll be attending.
A brief history of SDIX -- from Strategic Diagnostics (SDI) to SDIX.